Ghrelin and PYY Levels in Obesity From Brain Damage: Hypothalamic Obesity Hormones

Patients with hypothalamic obesity from structural brain damage showed elevated ghrelin and reduced PYY compared to BMI-matched controls, suggesting specific gut hormone dysregulation contributes to hypothalamic obesity.

Daousi, Christina et al.·The Journal of clinical endocrinology and metabolism·2005·Moderate EvidenceCross-Sectional
RPEP-01024Cross SectionalModerate Evidence2005RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Cross-Sectional
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Patients with acquired structural hypothalamic damage-induced obesity had elevated ghrelin and reduced PYY3-36 compared to matched controls, suggesting specific gut peptide dysregulation contributes to hypothalamic obesity beyond central appetite circuit damage.

Key Numbers

How They Did This

cross-sectional study on ghrp, neuropeptides.

Why This Research Matters

Relevant for ghrp, neuropeptides, weight-loss, clinical-trials.

The Bigger Picture

Advances peptide research with clinical implications.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding Patients with acquired structural hypothalamic damage-induced obesity had elevated ghrelin and reduced PYY3-36 compared to matched controls, suggestin
Evidence Grade:
moderate evidence.
Study Age:
Published in 2005.
Original Title:
Is there a role for ghrelin and peptide-YY in the pathogenesis of obesity in adults with acquired structural hypothalamic damage?
Published In:
The Journal of clinical endocrinology and metabolism, 90(9), 5025-30 (2005)
Database ID:
RPEP-01024

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

A snapshot of a population at one point in time.

What do these levels mean? →

Frequently Asked Questions

What was studied?

Ghrelin and PYY Levels in Obesity From Brain Damage: Hypothalamic Obesity Hormones

What was found?

Patients with hypothalamic obesity from structural brain damage showed elevated ghrelin and reduced PYY compared to BMI-matched controls, suggesting specific gut hormone dysregulation contributes to hypothalamic obesity.

Read More on RethinkPeptides

Cite This Study

RPEP-01024·https://rethinkpeptides.com/research/RPEP-01024

APA

Daousi, Christina; MacFarlane, Ian A; English, Patrick J; Wilding, John P H; Patterson, Michael; Dovey, Terence M; Halford, Jason C G; Ghatei, Mohammad A; Pinkney, Jonathan H. (2005). Is there a role for ghrelin and peptide-YY in the pathogenesis of obesity in adults with acquired structural hypothalamic damage?. The Journal of clinical endocrinology and metabolism, 90(9), 5025-30.

MLA

Daousi, Christina, et al. "Is there a role for ghrelin and peptide-YY in the pathogenesis of obesity in adults with acquired structural hypothalamic damage?." The Journal of clinical endocrinology and metabolism, 2005.

RethinkPeptides

RethinkPeptides Research Database. "Is there a role for ghrelin and peptide-YY in the pathogenes..." RPEP-01024. Retrieved from https://rethinkpeptides.com/research/daousi-2005-is-there-a-role

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.